The heart valve specialist saw better-than-expected TAVR sales in the first quarter as hospitals addressed capacity ...

the MITRIS RESILIA mitral surgical valve and the SAPIEN 3 Ultra RESILIA transcatheter aortic heart valve. Edwards’ INSPIRIS RESILIA and SAPIEN 3 Ultra RESILIA valves are supported by extensive ...

Edwards Lifesciences (NYSE: EW) today announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary RESILIA tissue technology have significantly ...

Edwards stock shot higher Thursday after the medtech player said tariffs are likely to have little impact in 2025.

Blood enters the left ventricle through the mitral valve and leaves through the aortic valve. A stenotic valve is a valve opening that has gotten smaller and is partially obstructing blood flow. In ...

Edwards Lifesciences Corporation ( NYSE: EW) Q1 2025 Earnings Conference Call April 23, 2025 5:00 PM ET Mark Wilterding - SVP, Global Finance Bernard Zovighian - CEO Scott Ullem - CFO Daveen Chopra - ...

Vivasure hope to find room in a competitive market with its surtureless implant that is absorbed 180 days after vessel ...

Vivasure Medical announced today that it received CE mark approval for its PerQseal Elite vascular closure system.

Analysts are estimating that Edwards Lifesciences will report an earnings per share (EPS) of $0.59. The announcement from ...

Orange County is home to some of the hottest medical device and biotechnology companies, producing a range of drugs and ...

This month: shorter recovery after TAVI, Down syndrome CV insights, the benefits of brisker walking, and more.